1. Home
  2. SME IPO
  • Quest Laboratories Ltd IPO
quest laboratories ipo

Quest Laboratories IPO

  • Status: Closed
  • RHP:
  • ₹ 111,600 / 1200 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    23 May 2024

  • Listing Price

    ₹ 155.10

  • Listing Change

    inf%

  • Last Traded Price

    ₹ 110.00

IPO Details

  • Open Date

    15 May 2024

  • Close Date

    17 May 2024

  • IPO Price Range

    ₹ 93 to ₹97

  • IPO Size

    ₹ 43.16 Cr

  • Listing Exchange

    NSE SME

  • Listing Date

    23 May 2024

With just a few clicks, Invest in IPOs!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Objective Financials SWOT FAQ Contacts

IPO Timeline

Quest Laboratories IPO Subscription Status

Last Updated: 28 May 2024 12:43 PM by 5Paisa

Last Updated: 16th May, 2024 by 5paisa

Quest Laboratories IPO is all set to open from 15th May to 17th May 2024. The company makes pharmaceutical formulations. The IPO includes a fresh issue of 4,449,600 shares worth ₹43.16 cr. The share allotment date is 21st May 2024, and the IPO will be listed on 23rd May 2024 on the stock exchanges. The price band is ₹93 to ₹97 and the lot size is 1200 shares.    

Shreni Shares Limited is the book-running lead manager for this IPO, while Bigshare Services Private Limited is the registrar. 

Objectives of Quest Laboratories IPO

Quest Laboratories Limited plans to utilize the raised capital from the IPO to:

●    To meet the working expenditure requirement to expand the current manufacturing unit by purchasing a plant and machinery. 
●    To meet the working Capital requirement.
●    General Corporate Purposes.

Quest Laboratories makes pharmaceutical formulations under the trademark “Quest Laboratories Limited”. This includes antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, etc. 

The company manufactures various products such as ethical drugs, generic drugs, and over the-counter drugs (OTC) in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. It has many certificates like WHO Schedule M GMP, and GLP certifications, ISO 9001:2015 certification and ISO/IEC 17025:2017 accreditation. 

Quest Laboratories’ manufacturing unit is based in Madhya Pradesh, India. It has a presence 12 states and 2 union territories in India including Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal Gujarat, Telangana, Haryana and Bihar b

Peer Comparison

●    Beta Drugs Limited
●    Alpa Laboratories Limited
●    Zenith Drugs Limited

For More Information:
Webstory on Quest Laboratories IPO

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY22 FY21
Revenue from operations 61.64 59.48 30.36
EBITDA 7.82 6.46 1.41
PAT 5.02 4.10 0.65
Particulars (in Rs. Crores) FY23 FY22 FY21
Total Assets 46.64 34.79 18.39
Share Capital 1.07 1.07 1.07
Total Borrowings 31.62 24.80 12.50
Particulars (in Rs. Crores) FY23 FY22 FY21
Net cash generated from / (used in) operating activities 3.63 3.45 1.04
Net cash from / (used in) investing activities -2.96 -1.88 -1.19
Net cash flow from / (used in) financing activities 0.27 -0.41 0.038
Net increase (decrease) in cash and cash equivalents 0.93 1.15 -0.11


Strengths

1.    The company has approvals to manufacture more than 600 formulations.
2.    Institutional and government business constitutes a vital segment of the company.
3.    It has a diverse and well-balanced product portfolio.
4.    It is a technology-driven organization supported by an extensive R&D department.
5.    The company also maintains high quality. 
6.    It has Supply Chain Efficiency. 
7.    Experienced Promoters and management team.
 

Risks

1.    Too much concentration of business is from sales to the government which may impact the business.
2.    It has reported negative cash flow in the past. 
3.    Operates in a highly competitive industry. 
4.    High working capital requirements.
 

Will You Apply for Quest Laboratories IPO?

Yes No Maybe
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Quest Laboratories IPO opens from 15th May to 17th May 2024.
 

The size of Quest Laboratories IPO is ₹43.16 cr. 
 

To apply for Quest Laboratories IPO, follow the steps given below:

●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for Quest Laboratories IPO.    
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

You will receive a mandate notification to block funds in your UPI app.
 

The price band of Quest Laboratories IPO is fixed at ₹93 to ₹97 per share. 
 

The minimum lot size of Quest Laboratories IPO is 1200 shares and the investment required is ₹1,11,600.
 

The share allotment date of Quest Laboratories IPO is 21st May 2024.
 

The Quest Laboratories IPO will be listed on 23rd May 2024.
 

Shreni Shares Limited is the book-running lead manager for Quest Laboratories IPO.
 

Quest Laboratories plans to utilize the raised capital from the IPO to:

●    To meet the working expenditure requirement to expand the current manufacturing unit by purchasing plant and machinery. 
●    To meet the working Capital requirement.
●    General Corporate Purposes.